Phenom, an AI company specializing in HR, announced 42 additions to its rapidly expanding IAMPHENOM 2025 speaker lineup — ...

Joseph W. Mattia, a lifelong resident of Braintree, peacefully passed away on February 9, 2025. A beloved husband, father, brother, and uncle, he will be leaving behind a long legacy of love and ...

NEW YORK/FRANKFURT, Feb 10 (Reuters) - (This Feb. 10 story has been refiled to say 'LOEs (loss of exclusivity),' not 'LOEs (levels of evidence),' in paragraph 13) Merck, in a statement ...

Mattia Preti, the very prolific baroque painter of the 17th century, is certainly very well-known in Malta where he spent the last 40 years of his life and where he produced hundreds of paintings ...

NEW YORK/FRANKFURT (Reuters) - Merck KGaA, the German healthcare and technology group, said on Monday it is in advanced talks to acquire U.S. cancer and rare diseases drugmaker SpringWorks ...

Now there’s a new one for the list: cancer prevention vaccines. Merck, which makes the commonly used Gardasil shot, has shed 14 per cent of its market value since announcing last week that it ...

Germany’s Merck MRK1.45%increase; green up pointing triangle KGaA said it is in advanced talks for a potential acquisition of SpringWorks Therapeutics SWTX 7.53%increase; green up pointing ...

NEW YORK/FRANKFURT — Merck KGaA, the German health care and technology group, said on Monday it is in advanced talks to acquire US cancer and rare diseases drugmaker SpringWorks Therapeutics. Merck, ...

At recent prices, you can buy shares of Merck (NYSE: MRK) that offer a yield above 3%, and shares of Pfizer (NYSE: PFE) offer a yield above 6%. Which of these two high-yield dividend payers is ...

Shares of Merck and Pfizer are way down from their previous peaks. Merck's lead drug, Keytruda, grew sales by 19% last year, but its era of patent-protected exclusivity is approaching its end.

Italian qualifier Mattia Bellucci caused another major upset in Rotterdam, knocking out Stefanos Tsitsipas to secure a place in the semi-final. This defeat is another disappointment for the Greek ...

Germany's Merck KGaA said it is in advanced talks for a potential acquisition of SpringWorks Therapeutics, a U.S. biopharmaceutical company that specializes in rare diseases and cancer.